共 50 条
Pharmacological evaluation of both enantiomers of (R,S)-BM-591 as thromboxane A2 receptor antagonists and thromboxane synthase inhibitors
被引:1
|作者:
Rolin, S
Dogne, JM
Vastersaegher, C
Hanson, J
Masereel, B
机构:
[1] Univ Namur, Dept Pharm, B-5000 Namur, Belgium
[2] Univ Liege, Nat & Synthet Drug Res Ctr, B-4000 Liege, Belgium
关键词:
thromboxane antagonist;
thromboxane synthase;
pharmacological evaluation;
thrombosis disorders;
D O I:
10.1016/j.prostaglandins.2004.07.007
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
The aim of this work is to evaluate the anti-thromboxane activity of two pure enantiomers of (R,S)-BM-591, a nitrobenzene sulfonylurea chemically related to torasemide, a loop diuretic. The drug affinity for thromboxane A2 receptor (TP) of human washed platelets has been determined. In these experiments, (R)-BM-591 (IC50 = 2.4 +/- 0.1 nM) exhibited a significant higher affinity than (S)-BM-591 (IC50 = 4.2 +/- 0.15 nM) for human washed platelets TP receptors. Both enantiomers were stronger ligands than SQ-29548 (IC50 = 21.0 +/- 1.0 nM) and sulotroban (IC50 = 930 +/- 42 nM), two reference TXA2 receptor antagonists. Pharmacological characterisations of (S)-BM-591 and (R)-BM-591 were compared in several models. Thus, (R)-BM-591 strongly prevented platelet aggregation induced by arachidonic acid (AA) (600 muM) and U-46619 (1 muM) while (S)-BM-591 showed a lower activity. On isolated tissues pre-contracted by U-46619, a stable TXA2 agonist, (S)-BM-591 was more potent in relaxing guinea-pig trachea (EC50 = 0.272 +/- 0.054 muM) and rat aorta (EC50 = 0.190 +/- 0.002 muM) than (R)-BM-591 (EC50 of 9.60 +/- 0.63 muM and 0.390 +/- 0.052 muM, respectively). Moreover, at 1 muM, (R)-BM-591 totally inhibited TXA2 synthase activity, expressed as TXB2 production from human platelets, while at the same concentration, (S)-BM-591 poorly reduced the TXB2 synthesis (22%). Finally, in rats, both enantiomers lost the diuretic activity of torasemide. In conclusion, (R)-BM-591 exhibits a higher affinity and antagonism on human platelet TP receptors than (S)-BM-591 as well as a better thromboxane synthase inhibitory potency. In contrast, (S)-BM-591 is more active than the (R)enantiomer in relaxing smooth muscle contraction of rat aorta and trachea guinea pig. Consequently, (R)-BM-591 represents the best candidate for further development in the field of thrombosis disorders. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:75 / 86
页数:12
相关论文